reference/24396673

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/24396673

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	14295
issn	0892-6638 1530-6860
issueIdentifier	12
pageRange	14281-14295
publicationName	FASEB journal : official publication of the Federation of American Societies for Experimental Biology
startingPage	14281
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_eb4f340a1767b2ff28113b9d3c67834b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e57a2df28cd3d691c9ebea9a73b49d7b
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_becc7fdfce13bb767d647dd691c06ac9
bibliographicCitation	Hartz AMS, Rempe RG, Soldner ELB, Pekcec A, Schlichtiger J, Kryscio R, Bauer B. Cytosolic phospholipase A2 is a key regulator of blood‐brain barrier function in epilepsy. The FASEB Journal. 2019 Oct 29;33(12):14281–95. doi: 10.1096/fj.201901369rr.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8ebca28d05edfeed27676b7408da0f63 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8ca9910fdb267005684a6b00c537643e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b820386234cce941ab96b6ac75b3b3ae http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4e65a71b433b8d7b02d5f2620ea6a84d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dc1a75e94322a881b1bc4365437d4e0b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_97da54f2596832c2ee8f09526c50abab http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7ca341bdfe457046a197df776d704b0d
date	2019-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/31661303 https://doi.org/10.1096/fj.201901369rr https://pubmed.ncbi.nlm.nih.gov/PMC6894050
isPartOf	https://portal.issn.org/resource/ISSN/1530-6860 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3815 https://portal.issn.org/resource/ISSN/0892-6638
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Cytosolic phospholipase A2 is a key regulator of blood‐brain barrier function in epilepsy
discusses	http://id.nlm.nih.gov/mesh/M0028010 http://id.nlm.nih.gov/mesh/M0222411
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D054513Q000378 http://id.nlm.nih.gov/mesh/D004827Q000201 http://id.nlm.nih.gov/mesh/D001812Q000201
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D015971Q000502 http://id.nlm.nih.gov/mesh/D001812Q000378 http://id.nlm.nih.gov/mesh/D015971Q000187 http://id.nlm.nih.gov/mesh/D002196Q000201 http://id.nlm.nih.gov/mesh/D018698Q000494 http://id.nlm.nih.gov/mesh/D004827Q000235 http://id.nlm.nih.gov/mesh/D005838 http://id.nlm.nih.gov/mesh/D001921Q000201 http://id.nlm.nih.gov/mesh/D001921Q000098 http://id.nlm.nih.gov/mesh/D017207 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D051381 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D054513Q000235 http://id.nlm.nih.gov/mesh/D000818
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID611 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.6.3.44 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4525487 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33032 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5128032 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_2b41adbd094947475b63355088c8b2f4 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7617 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460544 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23327 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14598502 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9299 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104813 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.1.1.4 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9191 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f1e4d7f806ea44eba476b32d2ebb4249 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ace030472dbfdca3d9134e3a72965c29

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID19225 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18783

Total number of triples: 68.